# Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy

> **NCT03616067** · PHASE3 · TERMINATED · sponsor: **Hospices Civils de Lyon** · enrollment: 23 (actual)

## Conditions studied

- Cerebral Palsy

## Interventions

- **DRUG:** Botox® injection
- **DRUG:** Scopoderm® patches arm

## Key facts

- **NCT ID:** NCT03616067
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-27
- **Primary completion:** 2025-09-22
- **Final completion:** 2025-09-22
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** The Steering Committee decided on 22/09/2025 to end the project, due to persistent issues: enrolment suspended because of supply shortages and the arrival of alternative treatments, as well as the end of a key supply agreement.
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03616067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03616067, "Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT03616067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*